Results 1 to 13 of 13
Page 1 of 1
TypeTitleAuthor(s)YearViews
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer modelsMa, BBY; Lui, VWY; Hui, CWC; Lau, CPY; Wong, CH; Hui, EP; Ng, MHL; Cheng, SH; Tsao, SW; Tsang, C-M; Cheung, CSF; Ho, K; Chan, ATC201423
 
Preclinical evaluation of the AKT inhibitor MK-2206 in nasophayryngeal carcinoma cell linesMa, BB; Lui, VW; Hui, CW; Lau, CP; Wong, CH; Hui, EP; Ng, MH; Tsao, GSW; Li, Y; Chan, AT201337
 
Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell linesMa, BBY; Lui, VWY; Hui, CWC; Lau, CPY; Wong, C-H; Hui, EP; Ng, MH; Tsao, SW; Li, Y; Chan, ATC201320
 
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell linesMa, BBY; Lui, VWY; Cheung, CS; Lau, CPY; Ho, K; Hui, EP; Tsui, SKW; Ng, MH; Cheng, SH; Ng, PKS; Tsao, SW; Chan, ATC201338
 
Targeting tumor hypoxia in nasopharyngeal carcinomaHong, B; Lui, VWY; Hashiguchi, M; Hui, EP; Chan, AT-C201311
 
Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activationHong, B; Lui, VWY; Hui, EP; Ng, MHL; Cheng, SH; Sung, FL; Tsang, CM; Tsao, SW; Chan, ATC2011272
 
FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: Implication for viral-mediated FGF8b upregulationLui, VWY; Yau, DMS; Cheung, CSF; Wong, SCC; Chan, AKC; Zhou, Q; Wong, EYL; Lau, CPY; Lam, EKY; Hui, EP; Hong, B; Hui, CWC; Chan, ASK; Ng, PKS; Ng, YK; Lo, KW; Tsang, CM; Tsui, SKW; Tsao, SW; Chan, ATC2011482
 
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinomaHui, EP; Lui, VWY; Wong, CSC; Ma, BBY; Lau, CPY; Cheung, CSF; Ho, K; Cheng, S-H; Ng, MHL; Chan, ATC201124
 
Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1Hong, B; Lui, VWY; Hui, EP; Lu, Y; Leung, HSY; Wong, EYL; Cheng, S-H; Ng, MHL; Mills, GB; Chan, ATC201026
 
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell linesMa, BBY; Lui, VWY; Hui, EP; Lau, CPY; Ho, K; Ng, MHL; Cheng, SH; Tsao, SW; Chan, ATC2010342
 
STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitroLui, VWY; Wong, EYL; Ho, Y; Hong, B; Wong, SCC; Tao, Q; Choi, GCG; Au, TCC; Ho, K; Yau, DMS; Ma, BBY; Hui, EP; Chan, ASK; Tsang, CM; Tsao, SW; Grandis, JR; Chan, ATC2009288
 
Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and β 2-tubulin for nasopharyngeal carcinomaChan, CML; Wong, SCC; Lam, MYY; Hui, EP; Chan, JKC; Lo, ESF; Cheuk, W; Wong, MCK; Tsao, SW; Chan, ATC2008144
 
Swallowing function after altered fractionation radiotherapy for head and neck carcinomaYu, KH; Chua, M; Vlantis, AC; Kam, MKM; Lee, WY; Tsang, RKY; Yuen, HY; Hui, EP; Chan, ATC2005153
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download